Premarket Gainer
GOVX Geovax Labs1.56+0.07+4.7%
Premarket:2.09+0.53 (+34.0%)
GeoVax Announces Issuance of Cancer Vaccine Patent
Globe NewswireTue, 22-Mar 9:00 AM
Premarket Gainer
GOVX Geovax Labs3.86-0.05-1.2%
Premarket:5.31+1.45 (+37.6%)
GeoVax Receives Notice of Allowance for Cancer Vaccine Patent
Globe NewswireTue, 16-Nov 9:00 AM
After Hours Gainer
GOVX Geovax Labs4.18-0.15-3.5%
After Hours:5.52+1.34 (+32.1%)
GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
Globe NewswireTue, 28-Sep 4:00 PM
After Hours Gainer
GOVX Geovax Labs4.14-0.19-4.4%
After Hours:5.66+1.52 (+36.7%)
GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
Globe NewswireTue, 28-Sep 4:00 PM
After Hours Gainer
GOVX Geovax Labs4.30+0.27+6.7%
After Hours:7.02+2.72 (+63.3%)
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly
Globe NewswireThu, 19-Aug 4:00 PM
After Hours Gainer
GOVX Geovax Labs4.30+0.27+6.7%
After Hours:5.09+0.79 (+18.4%)
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly
Globe NewswireThu, 19-Aug 4:00 PM